Boryung‘s blood pressure drug Kanarb reduces risk of strokes, vascular events: report
TechnologyAug 3, 2021
Boryung Pharmaceutical on Tuesday disclosed clinical trial results that showed its hypertension drug Kanarb is effective in controlling the blood pressure of patients who have experienced a stroke. By keeping patients’ blood pressure under control, the drug helped reduce the risk of recurrent strokes and major vascular events, it added. The clinical study was conducted at 27 medical institutions in Korea during a 24-week period, involving 1,035 patients who previously experienced an i